5491 related articles for article (PubMed ID: 11599893)
1. Molecular analysis in evaluating the sentinel node in malignant melanoma.
Sung J; Li W; Shivers S; Reintgen D
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):29S-30S. PubMed ID: 11599893
[TBL] [Abstract][Full Text] [Related]
2. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
3. Surgical and molecular approaches to the sentinel lymph nodes.
Essner R; Kojima M
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):31S-34S. PubMed ID: 11599894
[TBL] [Abstract][Full Text] [Related]
4. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
Roberts AA; Cochran AJ
J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
6. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
Kammula US; Ghossein R; Bhattacharya S; Coit DG
J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
[TBL] [Abstract][Full Text] [Related]
7. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in thin melanoma patients.
Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
[TBL] [Abstract][Full Text] [Related]
10. Detection of occult melanoma cells in sentinel lymph nodes and blood.
Reintgen DS; Conrad AJ
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
[TBL] [Abstract][Full Text] [Related]
11. Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
Blaheta HJ; Roeger S; Sotlar K; Schittek B; Breuninger H; Bueltmann B; Garbe C
Br J Dermatol; 2004 Mar; 150(3):477-83. PubMed ID: 15030330
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
13. Systematic search for the best gene expression markers for melanoma micrometastasis detection.
Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E
J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
15. Advances in molecular staging of melanoma patients: multimarker analysis of archival lymph node tissue.
Busam KJ
J Clin Oncol; 2003 Oct; 21(19):3550-1. PubMed ID: 12913105
[No Abstract] [Full Text] [Related]
16. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.
Gradilone A; Ribuffo D; Silvestri I; Cigna E; Gazzaniga P; Nofroni I; Zamolo G; Frati L; Scuderi N; Aglianò AM
Ann Surg Oncol; 2004 Nov; 11(11):983-7. PubMed ID: 15525827
[TBL] [Abstract][Full Text] [Related]
17. Molecular staging for patients with malignant melanoma.
Shivers S; Jakub J; Pendas S; Reintgen D
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1665-74. PubMed ID: 18020932
[TBL] [Abstract][Full Text] [Related]
18. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
19. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
[TBL] [Abstract][Full Text] [Related]
20. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
